Matches in Wikidata for { <http://www.wikidata.org/entity/Q66070673> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q66070673 description "clinical trial" @default.
- Q66070673 description "ensayu clínicu" @default.
- Q66070673 description "klinisch onderzoek" @default.
- Q66070673 description "клінічне випробування" @default.
- Q66070673 name "Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery" @default.
- Q66070673 name "Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery" @default.
- Q66070673 type Item @default.
- Q66070673 label "Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery" @default.
- Q66070673 label "Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery" @default.
- Q66070673 prefLabel "Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery" @default.
- Q66070673 prefLabel "Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery" @default.
- Q66070673 P1050 Q66070673-71A75E11-C1AF-4CF6-8EAF-4F1AC8962484 @default.
- Q66070673 P1132 Q66070673-404E10A2-63A1-4169-8B2B-BCD94DEB7495 @default.
- Q66070673 P1476 Q66070673-BBCF25C5-4453-4231-B758-F4DF90C98F05 @default.
- Q66070673 P17 Q66070673-97E6537F-D0FC-4EAE-95D5-4A43051493E3 @default.
- Q66070673 P2899 Q66070673-FD579741-43E3-4A42-901A-2BFC7A59D8E7 @default.
- Q66070673 P3098 Q66070673-9A592E3E-EB9C-45C2-B5EF-2DA9D4E71473 @default.
- Q66070673 P31 Q66070673-DE261B98-FF2E-446F-8394-EBDC70B733B1 @default.
- Q66070673 P580 Q66070673-51E7D9BA-5182-4E7B-97A5-D96E1D4E3812 @default.
- Q66070673 P582 Q66070673-35B134B1-8D73-4B43-86E2-D90428170AEC @default.
- Q66070673 P6099 Q66070673-6DCC04FB-5D30-4F51-8032-351A1971D4E8 @default.
- Q66070673 P6153 Q66070673-0F0B2727-AA1B-44A4-BA39-E551348FFFCA @default.
- Q66070673 P6153 Q66070673-14BA483E-7A23-469C-8D65-CE54878442E5 @default.
- Q66070673 P6153 Q66070673-2A116540-3466-4D74-AADB-5463D779423E @default.
- Q66070673 P6153 Q66070673-426F70B1-6FE4-4522-9F4D-D6861C29E7BE @default.
- Q66070673 P6153 Q66070673-6249C907-2830-4DD2-8E06-B2A010BA9419 @default.
- Q66070673 P6153 Q66070673-6FEE593A-4F3D-4DE3-9D25-80B421117285 @default.
- Q66070673 P6153 Q66070673-A8A460D1-37CD-4A29-8A57-1E6F000B9E80 @default.
- Q66070673 P6153 Q66070673-B5AB671B-8F75-477A-869E-EAA941EADE1E @default.
- Q66070673 P8363 Q66070673-E4F2B925-BC8D-4C8A-8B14-B5C638B1D3EF @default.
- Q66070673 P1050 Q223911 @default.
- Q66070673 P1132 "+46" @default.
- Q66070673 P1476 "A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma" @default.
- Q66070673 P17 Q30 @default.
- Q66070673 P2899 "+2" @default.
- Q66070673 P3098 "NCT03141684" @default.
- Q66070673 P31 Q30612 @default.
- Q66070673 P580 "2017-03-03T00:00:00Z" @default.
- Q66070673 P582 "2020-10-31T00:00:00Z" @default.
- Q66070673 P6099 Q42824440 @default.
- Q66070673 P6153 Q1130172 @default.
- Q66070673 P6153 Q193727 @default.
- Q66070673 P6153 Q235034 @default.
- Q66070673 P6153 Q30279912 @default.
- Q66070673 P6153 Q4897536 @default.
- Q66070673 P6153 Q49112 @default.
- Q66070673 P6153 Q7895888 @default.
- Q66070673 P6153 Q7972509 @default.
- Q66070673 P8363 Q78089383 @default.